For Cohort 2 which rolled into cohort 4 all patient finished dosing and been on mpl 28 days as of 28 April 2023 those patients who have continued on the extended trial have been on mpl for 490 days
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-699
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.005(2.38%) |
Mkt cap ! $95.68M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.5¢ | 21.0¢ | $12.24K | 58.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 138910 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 264423 | 2 |
View Market Depth
| Last trade - 10.44am 23/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |